These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 33548122

  • 1. The Role of Sphere Size in the Context of Pancreatin Therapy for Exocrine Pancreatic Insufficiency: A Systematic Review.
    Petersen KU, Malfertheiner P, Mössner J.
    J Gastrointestin Liver Dis; 2021 Mar 12; 30(1):132-141. PubMed ID: 33548122
    [Abstract] [Full Text] [Related]

  • 2. Fate of pancreatic enzymes in the human intestinal lumen in health and pancreatic insufficiency.
    Layer P, Gröger G.
    Digestion; 1993 Mar 12; 54 Suppl 2():10-4. PubMed ID: 7693530
    [Abstract] [Full Text] [Related]

  • 3. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
    Löhr JM, Hummel FM, Pirilis KT, Steinkamp G, Körner A, Henniges F.
    Eur J Gastroenterol Hepatol; 2009 Sep 12; 21(9):1024-31. PubMed ID: 19352190
    [Abstract] [Full Text] [Related]

  • 4. Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS.
    Maev IV, Kucheryavyy YA, Gubergrits NB, Bonnacker I, Shelest EA, Janssen-van Solingen GP, Domínguez-Muñoz JE.
    Drugs R D; 2020 Dec 12; 20(4):369-376. PubMed ID: 33211277
    [Abstract] [Full Text] [Related]

  • 5. New methods for assessment of enzyme activity: do they help to optimize enzyme treatment?
    Adler G, Mundlos S, Kühnelt P, Dreyer E.
    Digestion; 1993 Dec 12; 54 Suppl 2():3-9. PubMed ID: 7693531
    [Abstract] [Full Text] [Related]

  • 6. Optimal size range for enteric-coated pancreatin preparations.
    Lederer PC.
    Pancreas; 2011 Mar 12; 40(2):310-1. PubMed ID: 21311309
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of pellet size of a pancreas enzyme preparation on duodenal lipolytic activity].
    Kühnelt P, Mundlos S, Adler G.
    Z Gastroenterol; 1991 Sep 12; 29(9):417-21. PubMed ID: 1763562
    [Abstract] [Full Text] [Related]

  • 8. Gastric emptying of pancreatin granules and dietary lipids in pancreatic insufficiency.
    Nørregaard P, Lysgaard Madsen J, Larsen S, Worning H.
    Aliment Pharmacol Ther; 1996 Jun 12; 10(3):427-32. PubMed ID: 8791973
    [Abstract] [Full Text] [Related]

  • 9. Fate of oral enzymes in pancreatic insufficiency.
    Guarner L, Rodríguez R, Guarner F, Malagelada JR.
    Gut; 1993 May 12; 34(5):708-12. PubMed ID: 8504976
    [Abstract] [Full Text] [Related]

  • 10. Pancreatic enzyme therapy.
    Mössner J, Keim V.
    Dtsch Arztebl Int; 2010 Aug 12; 108(34-35):578-82. PubMed ID: 21904592
    [Abstract] [Full Text] [Related]

  • 11. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century.
    Trang T, Chan J, Graham DY.
    World J Gastroenterol; 2014 Sep 07; 20(33):11467-85. PubMed ID: 25206255
    [Abstract] [Full Text] [Related]

  • 12. Human postprandial gastric emptying of 1-3-millimeter spheres.
    Meyer JH, Elashoff J, Porter-Fink V, Dressman J, Amidon GL.
    Gastroenterology; 1988 Jun 07; 94(6):1315-25. PubMed ID: 3360258
    [Abstract] [Full Text] [Related]

  • 13. Mismatch of duodenal deliveries of dietary fat and pancreatin from enterically coated microspheres.
    Meyer JH, Lake R.
    Pancreas; 1997 Oct 07; 15(3):226-35. PubMed ID: 9336785
    [Abstract] [Full Text] [Related]

  • 14. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK, Rubin J, Harvey J.
    Gastroenterology; 1983 Mar 07; 84(3):476-82. PubMed ID: 6549746
    [Abstract] [Full Text] [Related]

  • 15. Enzyme treatment of exocrine pancreatic insufficiency in chronic pancreatitis.
    Lankisch PG.
    Digestion; 1993 Mar 07; 54 Suppl 2():21-9. PubMed ID: 8224569
    [Abstract] [Full Text] [Related]

  • 16. In vitro dissolution profiles of enteric-coated microsphere/microtablet pancreatin preparations at different pH values.
    Gan KH, Geus WP, Bakker W, Lamers CB, Heijerman HG.
    Aliment Pharmacol Ther; 1996 Oct 07; 10(5):771-5. PubMed ID: 8899086
    [Abstract] [Full Text] [Related]

  • 17. Yarrowia lipolytica Lipase 2 Is Stable and Highly Active in Test Meals and Increases Fat Absorption in an Animal Model of Pancreatic Exocrine Insufficiency.
    Aloulou A, Schué M, Puccinelli D, Milano S, Delchambre C, Leblond Y, Laugier R, Carrière F.
    Gastroenterology; 2015 Dec 07; 149(7):1910-1919.e5. PubMed ID: 26327131
    [Abstract] [Full Text] [Related]

  • 18. Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.
    Dutta SK, Hubbard VS, Appler M.
    Dig Dis Sci; 1988 Oct 07; 33(10):1237-44. PubMed ID: 3168696
    [Abstract] [Full Text] [Related]

  • 19. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency: when is it indicated, what is the goal and how to do it?
    Domínguez-Muñoz JE.
    Adv Med Sci; 2011 Oct 07; 56(1):1-5. PubMed ID: 21450558
    [Abstract] [Full Text] [Related]

  • 20. Duodenal instillation of pancreatin does not abolish steatorrhea in patients with pancreatic insufficiency.
    Zerega J, Lerner S, Meyer JH.
    Dig Dis Sci; 1988 Oct 07; 33(10):1245-9. PubMed ID: 3168697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.